{"nct_id":"NCT06140836","title":"A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2023-12-21","start_date_type":"ACTUAL","primary_completion_date":"2027-03-13","primary_completion_date_type":"ESTIMATED","completion_date":"2027-06-03","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}